China vs South Korea for Medical Tourism 2026: The Complete Comparison

When people think about medical tourism in East Asia, South Korea is usually the first country that comes to mind — especially for cosmetic surgery. And for good reason: in 2024, Korea received 1.17 million international medical tourists, of which 261,000 were from China alone (a 132% increase from the previous year). The numbers are staggering.

But the landscape is changing in 2026. Both countries have introduced new tax policies that affect medical tourism pricing. Safety concerns about Korea's "assembly line" clinics have been widely reported. And China's domestic cosmetic industry is fighting back with lower prices and better regulation. Let me break down where things stand right now.

The Price Gap (It's Still Big)

Let's be direct: Korea is still 3–5 times cheaper than China for most cosmetic and medical aesthetic procedures. Even with the 2026 tax changes I'll discuss below, Korea's base prices are so much lower that the gap remains substantial.

Procedure Cost Comparison

Sources: 36Kr cross-border analysis 2025, China News Weekly December 2025 report, Korean Ministry of Health and Welfare 2024 data, Jiemian News "Medical Beauty Special Forces" report.

2026 Policy Changes: What's Different Now

Two major changes happened on January 1, 2026, that affect the cost equation:

South Korea ended its 10% VAT refund for foreign medical tourists. For a decade, international patients could reclaim the 10% VAT on medical procedures. That's gone. This effectively adds 10% to the cost of Korean medical tourism.

China ended its VAT exemption for for-profit aesthetic medicine. A new 6% VAT now applies to cosmetic medical services. Domestic clinics will likely pass this cost to consumers, raising Chinese prices slightly.

The net effect: Korea's price advantage narrows by about 10%, but the gap remains very large. Industry analysts quoted by 36Kr expect a "K-shaped bifurcation" — high-end patients will continue going to Korea for cutting-edge, unapproved-in-China procedures, while price-sensitive patients may pivot to domestic chains or alternative destinations.

The Risks of Korean Medical Tourism

This is the part that Korean marketing doesn't talk about, and it deserves serious attention. Multiple Chinese investigative media outlets have documented significant problems.

• Price discrimination: Some Korean clinics charge Chinese patients 2x the local rate. Intermediary commissions can reach 20–50%, driving up the actual cost.
• Assembly line treatment: One patient interviewed by 36Kr had five procedures done in two hours. High-volume clinics prioritize speed over personalized care.
• Counterfeit devices: Fake ultrasound device tips and recycled equipment have been documented in Korean clinics serving foreign patients.
• Product sharing: Reports of botulinum toxin vials being divided among 3–5 patients to reduce costs — a serious safety violation.
• No follow-up: If complications arise after you return home, there's no practical way to get follow-up care from the Korean clinic.
• Legal recourse: Pursuing a malpractice claim in Korea as a foreigner is extremely difficult and expensive.

Where China Is The Better Choice

For patients who prioritize safety, traceability, and long-term follow-up over the absolute lowest price, China's top hospitals offer a compelling alternative.

Shanghai Ninth People's Hospital and PUMCH Plastic Surgery employ surgeons who perform hundreds of procedures annually in accredited teaching hospitals. The devices are registered and traceable. The products are verifiable. And if something goes wrong, you have legal recourse in China's court system.

Additionally, China is investing heavily in its domestic aesthetic industry. So-Young has opened 33 clinics across major cities with aggressive pricing. JD.com has opened aesthetic clinics in Beijing. The domestic industry is scaling fast and becoming more competitive every quarter.

The Bottom Line

For injectables and devices where you want the absolute lowest price and are willing to accept some risk: Korea is still the destination. Just do your research on the specific clinic, ask about commissions, and verify product authenticity.

For surgical procedures where safety and follow-up matter most: China's top hospitals offer good value, experienced surgeons, and the peace of mind that comes with an accredited medical system. You'll pay more than in Korea, but significantly less than in the West.

For cutting-edge procedures not yet approved in China: Korea (or Thailand) may be the only option, as China's NMPA approval process creates a gap of 3–5 years for some devices.